MAPK1 and cancer: It is not known how much of the full signaling capacity of the ERK pathway is used to stimulate cancer growth and by which extent the intensity of the ERK signaling driven by oncogenic mutations has to be suppressed by various feedbacks to allow for cancer cell proliferation.